Status:
COMPLETED
Observational Prospective Study Measuring the Impact of the Use of a Hypnotic Script Associated With Virtual Reality on the Pain of the Child's Sickle Cell During a Vaso-occlusive Crisis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of Virtual Reality induced Hypnosis on patients' pain scores, anxiety and the use of analgesics during a vaso-occlusive crisis
Detailed Description
Virtual reality hypnosis could probably reduce vaso-occlusive crisis-related (vaso-occlusive crisis) anxiety and pain and provide the patient with means of optimizing the ability to cope with the pain...
Eligibility Criteria
Inclusion
- Child over 6 years of age on the day of acceptance of the study (no upper limit)
- Suffering from sickle cell disease whatever genotype
- Admission in hospital for a VOC (vaso-occlusive crisis)
- Informed and signed consent by at least one legal guardian, if child is minor, and verbal agreement of the child himself.
Exclusion
- Deaf patient, visually impaired patient, claustrophobic and/or aquaphobic patient
- Patient not understanding French
- History of psychiatric illness such as paranoia, schizophrenia, manic-depressive psychosis, high suicide risk patient.
- The patient may be included several times in the study if he is hospitalized again during the inclusion period.
Key Trial Info
Start Date :
July 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 19 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04917120
Start Date
July 13 2021
End Date
July 19 2022
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Trousseau Hospital, General pediatric departement
Paris, France, 75012